Example: confidence
Pharmaceutical Regulations in Japan 2020
4.4 WHO International Drug Monitoring Program..... 134 5. PERIODIC INFECTION REPORTS FOR BIOLOGICAL PRODUCTS (ARTICLE 68-14 AND 68-24 IN THE LAW) ..... 135 6. REEXAMINATION SYSTEM (ARTICLE 14-4 AND 23-29 OF THE PHARMACEUTICAL AFFAIRS LAW)..... 135 6.1 Designation for Reexamination of
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: